NIKA Nika Pharmaceuticals, Inc.
Fundamentals / CIK 0001145604 / USDNika Pharmaceuticals, Inc. reported $5.3K in total assets and a net loss of $83K through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NIKA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$83K Operating profit
-
Net Income FY 2025-$83K GAAP bottom line
-
Diluted EPS FY 2025-$0.00 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$352 Total debt: $349K
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | -- | $0 | $0 | $0 | $0 | -- |
| Total Operating Expenses | $76K | $96K | $65K | $3.18M | $15K | $8.9K |
| Operating Income | -$76K | -$96K | -$65K | -$3.18M | -$15K | -$8.9K |
| Income Before Tax | -$76K | -$96K | -$65K | -$3.18M | -$15K | -$8.9K |
| Net Income | -$76K | -$96K | -$65K | -$3.18M | -$15K | -$8.9K |
| Basic EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 1.05B | 1.02B | 876.1M | 724.0M | 396.1M | 13.2M |
| Diluted Shares Outstanding | 1.05B | 1.02B | 876.1M | 724.0M | 396.1M | 13.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Operating Expenses | $13K | $20K | $13K | $37K | $8.0K | $18K | $13K | $12K |
| Operating Income | -$13K | -$20K | -$13K | -$37K | -$8.0K | -$18K | -$13K | -$12K |
| Income Before Tax | -$13K | -$20K | -$13K | -$37K | -$8.0K | -$18K | -$13K | -$12K |
| Net Income | -$13K | -$20K | -$13K | -$37K | -$8.0K | -$18K | -$13K | -$12K |
| Basic EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Diluted EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 1.05B | 1.05B | 1.05B | -- | 1.04B | 1.03B | 1.03B | -- |
| Diluted Shares Outstanding | 1.05B | 1.05B | 1.05B | -- | 1.04B | 1.03B | 1.03B | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.9K | $2.1K | $20K | $864 | $399 | $1.6K |
| Cash & Short-Term Investments | $1.9K | $2.1K | $20K | $864 | $399 | $1.6K |
| Total Current Assets | $21K | $18K | $20K | $864 | $399 | $1.6K |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $21K | $18K | $20K | $864 | $399 | $1.6K |
| Short-Term Debt | $319K | $239K | $102K | $18K | -- | -- |
| Total Current Liabilities | $319K | $239K | $102K | $18K | $11K | -- |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $14K | -- |
| Total Liabilities | $319K | $239K | $102K | $18K | $24K | $11K |
| Total Debt (incl. Leases) | $319K | $239K | $102K | $18K | -- | -- |
| Common Stock | $105K | $102K | $88K | $88K | $40K | $13K |
| Retained Earnings | -$9.00M | -$8.93M | -$3.40M | -$3.34M | $152K | $137K |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | $137K |
| Total Stockholders' Equity | -$298K | -$221K | -$82K | -$17K | -$24K | -$8.9K |
| Total Equity | -$298K | -$221K | -$82K | -$17K | -$24K | -$8.9K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $352 | $2.9K | $1.5K | $1.9K | $6.3K | $16K | $19K | $2.1K |
| Cash & Short-Term Investments | $352 | $2.9K | $1.5K | $1.9K | $6.3K | $16K | $19K | $2.1K |
| Total Current Assets | $5.3K | $9.9K | $21K | $21K | $24K | $32K | $35K | $18K |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $5.3K | $9.9K | $21K | $21K | $24K | $32K | $35K | $18K |
| Short-Term Debt | $349K | $341K | $332K | $319K | $284K | $284K | $269K | $239K |
| Total Current Liabilities | $349K | $341K | $332K | $319K | $284K | $284K | $269K | $239K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $349K | $341K | $332K | $319K | $284K | $284K | $269K | $239K |
| Total Debt (incl. Leases) | $349K | $341K | $332K | $319K | $284K | $284K | $269K | $239K |
| Common Stock | $105K | $105K | $105K | $105K | $104K | $103K | $103K | $102K |
| Retained Earnings | -$9.05M | -$9.04M | -$9.02M | -$9.00M | -$8.97M | -$8.96M | -$8.94M | -$8.93M |
| Total Stockholders' Equity | -$344K | -$331K | -$311K | -$298K | -$261K | -$253K | -$234K | -$221K |
| Total Equity | -$344K | -$331K | -$311K | -$298K | -$261K | -$253K | -$234K | -$221K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$76K | -$96K | -$65K | -$3.18M | $15K | -$8.9K |
| Change in Working Capital | -- | -- | -- | -- | -$10K | -- |
| Operating Cash Flow | -$80K | -$155K | -$65K | $34K | $15K | -$8.9K |
| Common Stock Issued | -- | -- | -- | $10K | -- | -- |
| Financing Cash Flow | $79K | $137K | $84K | $34K | $14K | $11K |
| Net Change in Cash | -$194 | -$18K | $19K | $465 | -$1.2K | $1.6K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$13K | -$20K | -$13K | -$37K | -$8.0K | -$18K | -$13K | -$12K |
| Operating Cash Flow | -$11K | -$7.6K | -$13K | -$39K | -$9.3K | -$19K | -$13K | -$28K |
| Financing Cash Flow | $8.4K | $9.0K | $13K | $34K | $0 | $15K | $30K | $29K |
| Net Change in Cash | -$2.6K | $1.4K | -$359 | -$4.4K | -$9.3K | $31K | -$17K | $697 |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -363.9% | -534.1% | -330.8% | -368485.5% | -3687.2% | -552.9% |
| Current Ratio | 0.07x | 0.07x | 0.19x | 0.05x | 0.04x | -- |
| Quick Ratio | 0.01x | 0.01x | 0.19x | 0.05x | 0.04x | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -292.3% | +129.2% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -1566.5% | -785.8% | -372.2% | -363.9% | -219.1% | -165.0% | -160.7% | -497.5% |
| Current Ratio | 0.02x | 0.03x | 0.06x | 0.07x | 0.08x | 0.11x | 0.13x | 0.07x |
| Quick Ratio | 0.00x | 0.01x | 0.00x | 0.01x | 0.02x | 0.05x | 0.07x | 0.01x |